Showing 8791-8800 of 18119 results for "".
- Renerva's Pioneering Step in Neuroma Pain Management: IDE Approval for First-in-Human Study of PNM-CAP Devicehttps://reachmd.com/news/renervas-pioneering-step-in-neuroma-pain-management-ide-approval-for-first-in-human-study-of-pnm-cap-device/2484758/Renerva receives FDA IDE approval to open a first-in-human study of its PNM-CAP device aimed at preventing neuroma formation in amputees and reducing opioid reliance. Renerva has received
- Harnessing Pharmacogenetics: New Clopidogrel Guidelines and Their Clinical Implicationshttps://reachmd.com/news/harnessing-pharmacogenetics-new-clopidogrel-guidelines-and-their-clinical-implications/2484755/The UK CERSI-PGx guideline 2025 now recommends routine CYP2C19 pharmacogenetic testing before initiating clopidogrel, citing patient safety and the need to match antiplatele
- Navigating Hepatitis B Vaccination Policy: Insights from the Latest ACIP Deliberationhttps://reachmd.com/news/navigating-hepatitis-b-vaccination-policy-insights-from-the-latest-acip-deliberation/2484774/At a recent ACIP meeting, the Advisory Committee on Immunization Practices examined
- Emerging Therapeutics and Molecular Insights in Rheumatoid Arthritishttps://reachmd.com/news/therapeutics-molecular-insights-rheumatoid-arthritis/2484720/The USP5/METTL14/GLUT1 axis has emerged as a molecular pivot that links a deubiquitinase to m6A-mediated control of GLUT1 and drives glycolytic reprogramming with inflammatory activati
- Hepatitis B Birth Dose Timing: Understanding Clinical Impactshttps://reachmd.com/news/hepatitis-b-birth-dose-timing/2484724/New modeling from the Vaccine Integrity Project based at the University of Minnesota projects roughly 99,000 potentially preventable hepatitis B infections through 2050 if routine birth-d
- Mapping Risks: PAD Amputation Trends and New Insights into AFib-OSA Comorbiditieshttps://reachmd.com/news/mapping-risks-pad-amputation-trends-and-new-insights-into-afib-osa-comorbidities/2484710/The PAD Collaborative has released a new interactive amputation map that reveals marked regional disparities in peripheral artery disease (PAD)–related lower-limb amputations, pinpointing geographic hotspots that could guide screening and referral priorities. The
- Regulatory Milestones and Clinical Impact of Otsuka's Voyxact in IgA Nephropathy Treatmenthttps://reachmd.com/news/regulatory-milestones-and-clinical-impact-of-otsukas-voyxact-in-iga-nephropathy-treatment/2484695/The FDA has granted accelerated approval to Otsuka's Voyxact for adults with primary IgA nephropathy (IgAN) at risk f
- Exploring the Role of Compounded Imiquimod in Ocular Surface Cancershttps://reachmd.com/news/exploring-the-role-of-compounded-imiquimod-in-ocular-surface-cancers/2484705/Compounded imiquimod 5% ointment was evaluated in a five-patient interventional case series for ocular surface malignancies, producing focal complete histologi
- Immunization Counseling and Misinformation: Updates from AAPhttps://reachmd.com/news/immunization-counseling-misinformation/2484683/The American Academy of Pediatrics has secured the introduction of CPT codes 90482–90484—an explicit, billable pathway for s
- Revolutionizing Prostate Cancer Diagnosis: The Role of IsoPSA and AIhttps://reachmd.com/news/revolutionizing-prostate-cancer-diagnosis-the-role-of-isopsa-and-ai/2484700/IsoPSA was approved by the FDA as an aid in diagnosing high‑grade prostate cancer and refining